Literature DB >> 12433881

Impact of age and sex on sudden cardiovascular death following myocardial infarction.

S Z Abildstrom1, C Rask-Madsen, M M Ottesen, P K Andersen, S Rosthøj, C Torp-Pedersen, L Køber.   

Abstract

OBJECTIVE: To evaluate and compare the risk of sudden cardiovascular death (SCD) and non-SCD after myocardial infarction (MI) associated with age and sex.
DESIGN: Cohort study of patients admitted with an enzyme verified acute MI and discharged alive. Patients were followed up for up to four years. PATIENTS: 5983 consecutive hospital survivors of acute MI were enrolled in the TRACE (trandolapril cardiac evaluation) registry from 1990-92. Four age groups were prespecified: < 56, 56-65, 66-75, and > or = 76 years. MAIN OUTCOME MEASURES: SCD was defined as cardiovascular death within one hour of onset of symptoms.
RESULTS: There were 536 SCD and 725 non-SCD. SCD mortality was 4.8% in the youngest and 15.7% in the oldest age groups. Non-SCD mortality was 3.5% and 25%, respectively. The ratio of SCD to non-SCD mortality varied from 1.44 in the youngest (< 56 years) to 0.55 in the oldest patients (> or = 76 years). Age significantly increased both SCD and non-SCD risk (p < 0.0001), but the increase in non-SCD risk was 40% higher (p < 0.0001). Male sex was associated with increased risk of SCD independently of age (risk ratio 1.34, p < 0.005). However, the absolute three year probability of SCD among women older than 66 years exceeded 10%.
CONCLUSIONS: Compared with non-SCD the risk of SCD is relatively highest in the younger age groups, but the absolute risk of SCD is much higher among the upper age groups than the younger. The risk of SCD was slightly lower in women but not enough to warrant a different treatment strategy.

Entities:  

Mesh:

Year:  2002        PMID: 12433881      PMCID: PMC1767447          DOI: 10.1136/heart.88.6.573

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  33 in total

1.  Task Force on Sudden Cardiac Death of the European Society of Cardiology.

Authors:  S G Priori; E Aliot; C Blomstrom-Lundqvist; L Bossaert; G Breithardt; P Brugada; A J Camm; R Cappato; S M Cobbe; C Di Mario; B J Maron; W J McKenna; A K Pedersen; U Ravens; P J Schwartz; M Trusz-Gluza; P Vardas; H J Wellens; D P Zipes
Journal:  Eur Heart J       Date:  2001-08       Impact factor: 29.983

2.  Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.

Authors:  S J Connolly; A P Hallstrom; R Cappato; E B Schron; K H Kuck; D P Zipes; H L Greene; S Boczor; M Domanski; D Follmann; M Gent; R S Roberts
Journal:  Eur Heart J       Date:  2000-12       Impact factor: 29.983

3.  Precursors of sudden coronary death. Factors related to the incidence of sudden death.

Authors:  W B Kannel; J T Doyle; P M McNamara; P Quickenton; T Gordon
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

4.  Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants.

Authors:  V Vaccarino; L Parsons; N R Every; H V Barron; H M Krumholz
Journal:  N Engl J Med       Date:  1999-07-22       Impact factor: 91.245

5.  Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study.

Authors:  R Sheldon; S Connolly; A Krahn; R Roberts; M Gent; M Gardner
Journal:  Circulation       Date:  2000-04-11       Impact factor: 29.690

6.  Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. Multicentre international study: supplementary report.

Authors: 
Journal:  Br Med J       Date:  1977-08-13

7.  Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.

Authors: 
Journal:  JAMA       Date:  1995-01-18       Impact factor: 56.272

8.  Influence of age on the relation between heart rate variability, left ventricular ejection fraction, frequency of ventricular extrasystoles, and sudden death after myocardial infarction.

Authors:  O Odemuyiwa; T G Farrell; M Malik; Y Bashir; T Millane; T Cripps; J Poloniecki; D Bennett; A J Camm
Journal:  Br Heart J       Date:  1992-05

9.  An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study). TRAndolapril Cardiac Evaluation.

Authors:  L Køber; C Torp-Pedersen; J Carlsen; R Videbaek; H Egeblad
Journal:  Eur Heart J       Date:  1994-12       Impact factor: 29.983

10.  Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1981-04-02       Impact factor: 91.245

View more
  9 in total

1.  What's bad for the gander...women and sudden cardiac death.

Authors:  W J Groh; E von der Lohe; D P Zipes
Journal:  Heart       Date:  2002-12       Impact factor: 5.994

2.  Is there a sex bias in implantable cardioverter-defibrillator referral and prescription?

Authors:  A D Staniforth; S C Sporton; N M Robinson; J Cooper; M J Earley; A W Nathan; R J Schilling
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

3.  Sex differences in cardiomyocyte connexin43 expression.

Authors:  Brian L Stauffer; Rebecca D Sobus; Carmen C Sucharov
Journal:  J Cardiovasc Pharmacol       Date:  2011-07       Impact factor: 3.105

4.  Sudden death after myocardial infarction.

Authors:  A Selcuk Adabag; Terry M Therneau; Bernard J Gersh; Susan A Weston; Véronique L Roger
Journal:  JAMA       Date:  2008-11-05       Impact factor: 56.272

5.  A Study of 100 Cases of Arrhythmias in First Week of Acute Myocardial Infarction (AMI) in Gujarat: A High Risk and Previously Undocumented Population.

Authors:  Mohit J Shah; Nikita R Bhatt; Ajay Dabhi; P B Thorat; Ketan Chudasama; Jigar Patel
Journal:  J Clin Diagn Res       Date:  2013-01-12

6.  Pharmacological interventions for heart failure in people with chronic kidney disease.

Authors:  Meaghan Lunney; Marinella Ruospo; Patrizia Natale; Robert R Quinn; Paul E Ronksley; Ioannis Konstantinidis; Suetonia C Palmer; Marcello Tonelli; Giovanni Fm Strippoli; Pietro Ravani
Journal:  Cochrane Database Syst Rev       Date:  2020-02-27

7.  Risk factors for sudden cardiac death to determine high risk patients in specific patient populations that may benefit from a wearable defibrillator.

Authors:  Hilal Mohammed Khan; Stephen J Leslie
Journal:  World J Cardiol       Date:  2019-03-26

8.  Characteristics, management and attainment of lipid target levels in diabetic and cardiac patients enrolled in Disease Management Program versus those in routine care: LUTZ registry.

Authors:  Kurt Bestehorn; Christina Jannowitz; Barbara Karmann; David Pittrow; Wilhelm Kirch
Journal:  BMC Public Health       Date:  2009-08-04       Impact factor: 3.295

Review 9.  Individual patient data network meta-analysis of mortality effects of implantable cardiac devices.

Authors:  B Woods; N Hawkins; S Mealing; A Sutton; W T Abraham; J F Beshai; H Klein; M Sculpher; C J Plummer; M R Cowie
Journal:  Heart       Date:  2015-08-12       Impact factor: 5.994

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.